• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞病中部分脾切除术与全脾切除术的比较:一项系统评价和荟萃分析。

Partial Splenectomy Versus Total Splenectomy in Sickle Cell Disease: A Systematic Review and Meta-Analysis.

作者信息

Roshdy Merna Raafat, Botros Mina, Mokhles Abanoub, Aldemerdash Mohamed A, Sabet Haneen, Fahim Bishoy, Hindawi Mahmoud Diaa

机构信息

Faculty of Medicine, Sohag University, 82511 Sohag, Egypt; Medical Research Group of Egypt, Negida Academy, Arlington, MA, USA.

Faculty of Medicine, Sohag University, 82511 Sohag, Egypt; Medical Research Group of Egypt, Negida Academy, Arlington, MA, USA.

出版信息

J Pediatr Surg. 2025 Feb;60(2):162058. doi: 10.1016/j.jpedsurg.2024.162058. Epub 2024 Nov 5.

DOI:10.1016/j.jpedsurg.2024.162058
PMID:39541930
Abstract

BACKGROUND

Sickle cell disease (SCD) patients encounter various complications, such as acute splenic sequestration crisis and hypersplenism that may require splenectomy. This systematic review and meta-analysis aims to clarify differences between total splenectomy (TS) or partial splenectomy (PS) in terms of hematological and postoperative outcomes.

METHODS

We identified studies involving SCD patients who underwent PS or TS, whether open or laparoscopic, and whose hematological and operative outcomes were evaluated, through searching PubMed, Web of Science, Scopus, Embase and Cochrane databases from inception until June 2024.

PRIMARY OUTCOMES

hemoglobin concentration and reticulocytes %.

SECONDARY OUTCOMES

operative blood transfusion need, length of hospital stay (LoS), postoperative infections, overwhelming postsplenectomy sepsis (OPSS), acute chest syndrome (ACS), thromboembolic events and mortality.

RESULTS

Eighteen studies were included; 17 cohort and one case series. Seven studies collected data from the same SICHA institutions, so a total of 756 SCD patients is included. According to the most recent study, no significant changes in hemoglobin (preoperative 10.5 ± 0.3 vs 9.6 ± 0.4 one year postoperative in 24 PS cases, and 9.7 ± 0.1 vs 9.7 ± 0.2 in 73 TS cases), however, both TS and PS significantly decreased reticulocyte by 2 % (0.8-3.2 %). Proportional analysis of short-term infection revealed a lower incidence in TS 2.71 % vs 8.64 % in PS, and similarly for ACS, it is 6.97 % in TS vs 14.90 % in PS.

CONCLUSION

This first systematic review and meta-analysis shows that TS and PS have no or minimal effect on hemoglobin but a strong lowering effect on reticulocyte %. Proportional analysis reveals lower short-term infections and ACS following TS than PS. However, further clinical trials are necessary to draw definite conclusions and improve surgical decision making.

TYPE OF STUDY

Systematic review and meta-analysis of cohort studies.

LEVEL OF EVIDENCE

II.

摘要

背景

镰状细胞病(SCD)患者会遭遇各种并发症,如急性脾滞留危象和脾功能亢进,可能需要进行脾切除术。本系统评价和荟萃分析旨在阐明全脾切除术(TS)或部分脾切除术(PS)在血液学和术后结局方面的差异。

方法

我们通过检索PubMed、Web of Science、Scopus、Embase和Cochrane数据库,从数据库建立至2024年6月,识别了涉及接受PS或TS的SCD患者的研究,无论手术方式是开放手术还是腹腔镜手术,且对其血液学和手术结局进行了评估。

主要结局

血红蛋白浓度和网织红细胞百分比。

次要结局

手术输血需求、住院时间(LoS)、术后感染、脾切除术后暴发性感染(OPSS)、急性胸综合征(ACS)、血栓栓塞事件和死亡率。

结果

纳入18项研究;17项队列研究和1项病例系列研究。7项研究收集了来自同一SICHA机构的数据,因此共纳入756例SCD患者。根据最新研究,血红蛋白无显著变化(24例PS患者术前为10.5±0.3,术后1年为9.6±0.4;73例TS患者术前为9.7±0.1,术后为9.7±0.2),然而,TS和PS均使网织红细胞显著降低2%(0.8 - 3.2%)。短期感染的比例分析显示,TS的发生率较低,为2.71%,而PS为8.64%;同样,ACS方面,TS为6.97%,PS为14.90%。

结论

这项首次系统评价和荟萃分析表明,TS和PS对血红蛋白无影响或影响极小,但对网织红细胞百分比有显著降低作用。比例分析显示,TS术后短期感染和ACS低于PS。然而,需要进一步的临床试验才能得出明确结论并改善手术决策。

研究类型

队列研究的系统评价和荟萃分析。

证据水平

II级。

相似文献

1
Partial Splenectomy Versus Total Splenectomy in Sickle Cell Disease: A Systematic Review and Meta-Analysis.镰状细胞病中部分脾切除术与全脾切除术的比较:一项系统评价和荟萃分析。
J Pediatr Surg. 2025 Feb;60(2):162058. doi: 10.1016/j.jpedsurg.2024.162058. Epub 2024 Nov 5.
2
Preoperative blood transfusions for sickle cell disease.镰状细胞病的术前输血
Cochrane Database Syst Rev. 2016 Apr 6;4(4):CD003149. doi: 10.1002/14651858.CD003149.pub3.
3
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟脲)治疗镰状细胞病。
Cochrane Database Syst Rev. 2022 Sep 1;9(9):CD002202. doi: 10.1002/14651858.CD002202.pub3.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
7
Folate supplementation in people with sickle cell disease.镰状细胞病患者的叶酸补充
Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011130. doi: 10.1002/14651858.CD011130.pub3.
8
Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease.镰状细胞病患者急性脾梗死危机的脾切除术与保守治疗对比
Cochrane Database Syst Rev. 2017 Nov 7;11(11):CD003425. doi: 10.1002/14651858.CD003425.pub4.
9
Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease.镰状细胞病患者急性脾滞留危象的脾切除术与保守治疗对比
Cochrane Database Syst Rev. 2015 Sep 7(9):CD003425. doi: 10.1002/14651858.CD003425.pub3.
10
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.